Ivermectin Augments the Anti-Cancer Activity of Pitavastatin in Ovarian Cancer Cells
We have previously shown that pitavastatin has the potential to be used to treat ovarian cancer, although relatively high doses are likely to be necessary. One solution to this problem is to identify drugs that are synergistic with pitavastatin, thereby reducing the dose that is necessary to have a...
Main Authors: | Mohammed Jasim Jawad, Alan Richardson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Diseases |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-9721/11/1/49 |
Similar Items
-
Mini-Review on the efficacy and safety of pitavastatin: “The novel seventh statin gaining momentum”
by: Azza Ramadan, et al.
Published: (2022-01-01) -
Enhancement of the Solubility and Bioavailability of Pitavastatin through a Self-Nanoemulsifying Drug Delivery System (SNEDDS)
by: Mehran Ashfaq, et al.
Published: (2022-02-01) -
Analytical method development of pitavastatin-loaded SNEDDS formulation: Multivariate analysis regarding ultraviolet spectrophotometry analysis
by: Kuncahyo I, et al.
Published: (2019-01-01) -
Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome
by: Hyo-Sun Lee, et al.
Published: (2016-03-01) -
Pitavastatin ameliorates myocardial damage by preventing inflammation and collagen deposition via reduced free radical generation in isoproterenol-induced cardiomyopathy
by: Ramsha Iqbal, et al.
Published: (2019-07-01)